Brokerages Set Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Price Target at $43.00
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. The average 12-month […]
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. The average 12-month […]
